Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Kerr · SciRah

Researcher profile · Semantic Scholar

K. Kerr

Share profile

K. Kerr — researcher profile on SciRah

h-index: 82
Works: 346
Citations: 41K

Most-cited papers

Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer
P. Forde, J. Spicer, Shun Lu, M. Provencio +25 more
2022New England Journal of Medicine2,230 citations Open access
Semantic Scholar
The 2021 WHO Classification of Lung Tumors: Impact of advances since 2015.
A. Nicholson, M. Tsao, M. Beasley, A. Borczuk +15 more
2021Journal of Thoracic Oncology1,472 citations Open access
Semantic Scholar
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
D. Doroshow, S. Bhalla, M. Beasley, L. Sholl +6 more
2021Nature Reviews Clinical Oncology1,356 citations
Semantic Scholar
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
P. Postmus, K. Kerr, M. Oudkerk, S. Senan +4 more
2017Annals of Oncology1,301 citations Open access
Semantic Scholar
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
N. Lindeman, P. Cagle, D. Aisner, M. Arcila +18 more
2018Journal of Thoracic Oncology971 citations Open access
Semantic Scholar
PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project
M. Tsao, K. Kerr, M. Kockx, M. Beasley +24 more
2018Journal of Thoracic Oncology712 citations Open access
Semantic Scholar
Lung adenocarcinoma promotion by air pollutants
William Hill, Emilia L. Lim, C. Weeden, Claudia Lee +322 more
2023Nature710 citations Open access
Semantic Scholar
Non-oncogene addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†.
L. Hendriks, K. Kerr, J. Menis, T. Mok +8 more
2023Annals of Oncology574 citations Open access
Semantic Scholar
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies
F. Arce Vargas, A. Furness, K. Litchfield, K. Joshi +251 more
2018Cancer Cell554 citations Open access
Semantic Scholar
A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee
A. Moreira, P. Ocampo, Yu-He Xia, Hua Zhong +40 more
2020Journal of Thoracic Oncology498 citations Open access
Semantic Scholar
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology.
N. Lindeman, P. Cagle, D. Aisner, M. Arcila +18 more
2018Archives of Pathology & Laboratory Medicine434 citations Open access
Semantic Scholar
IASLC MULTIDISCIPLINARY RECOMMENDATIONS FOR PATHOLOGIC ASSESSMENT OF LUNG CANCER RESECTION SPECIMENS FOLLOWING NEOADJUVANT THERAPY
W. Travis, S. Dacic, I. Wistuba, L. Sholl +39 more
2020Journal of Thoracic Oncology432 citations Open access
Semantic Scholar
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors
F. Arce Vargas, A. Furness, I. Solomon, K. Joshi +245 more
2017Immunity386 citations Open access
Semantic Scholar
Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA
C. Abbosh, A. Frankell, T. Harrison, Judit Kisistók +302 more
2023Nature355 citations Open access
Semantic Scholar
Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer
Y. Yatabe, S. Dacic, A. Borczuk, A. Warth +28 more
2018Journal of Thoracic Oncology331 citations Open access
Semantic Scholar
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
D. Planchard, S. Popat, K. Kerr, S. Novello +7 more
2019Annals of Oncology299 citations Open access
Semantic Scholar
PD-L1 Testing for Lung Cancer in 2019: Perspective from the IASLC Pathology Committee.
S. Lantuejoul, Ming Sound-Tsao, W. Cooper, N. Girard +34 more
2019Journal of Thoracic Oncology286 citations Open access
Semantic Scholar
The evolution of lung cancer and impact of subclonal selection in TRACERx
A. Frankell, M. Dietzen, Maise Al Bakir, Emilia L. Lim +76 more
2023Nature275 citations Open access
Semantic Scholar
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology.
N. Lindeman, P. Cagle, D. Aisner, M. Arcila +18 more
2018Journal of Molecular Diagnostics265 citations Open access
Semantic Scholar
The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee
L. Sholl, F. Hirsch, D. Hwang, J. Botling +34 more
2020Journal of Thoracic Oncology256 citations Open access
Semantic Scholar
Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis
J. Field, D. Vulkan, M. Davies, D. Baldwin +24 more
2021The Lancet Regional Health - Europe231 citations Open access
Semantic Scholar
The evolution of non-small cell lung cancer metastases in TRACERx
Maise Al Bakir, Ariana Huebner, Carlos Martínez-Ruiz, Kristiana Grigoriadis +282 more
2023Nature217 citations Open access
Semantic Scholar
RETRACTED ARTICLE: Antibodies against endogenous retroviruses promote lung cancer immunotherapy
K. Ng, J. Boumelha, K. Enfield, J. Almagro +327 more
2023Nature202 citations Open access
Semantic Scholar
British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma
I. Woolhouse, L. Bishop, L. Darlison, D. de Fonseka +13 more
2018Thorax191 citations Open access
Semantic Scholar
The International Association for the Study of Lung Cancer (IASLC) Global Survey on Molecular Testing in Lung Cancer.
M. Smeltzer, M. Wynes, S. Lantuejoul, R. Soo +21 more
2019Journal of Thoracic Oncology189 citations Open access
Semantic Scholar
The evolving landscape of biomarker testing for non-small cell lung cancer in Europe.
K. Kerr, F. Bibeau, E. Thunnissen, J. Botling +6 more
2021Lung Cancer179 citations Open access
Semantic Scholar
Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective from the IASLC Pathology Committee.
M. Mino-Kenudson, K. Schalper, W. Cooper, S. Dacic +14 more
2022Journal of Thoracic Oncology178 citations Open access
Semantic Scholar
The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases
E. Thunnissen, A. Borczuk, D. Flieder, B. Witte +35 more
2017Journal of Thoracic Oncology139 citations Open access
Semantic Scholar
PD-1 blockade in advanced NSCLC: A focus on pembrolizumab.
S. Peters, K. Kerr, R. Stahel
2018Cancer Treatment Reviews129 citations Open access
Semantic Scholar
KRAS G12C in advanced NSCLC: Prevalence, co-mutations, and testing.
T. Lim, F. Skoulidis, K. Kerr, M. Ahn +3 more
2023Lung Cancer120 citations Open access
Semantic Scholar
Surgical outcomes from the phase 3 CheckMate 816 trial: Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo alone as neoadjuvant treatment for patients with resectable non-small cell lung cancer (NSCLC).
J. Spicer, Changli Wang, F. Tanaka, G. Saylors +16 more
2021107 citations
Semantic Scholar
New Insights on Diagnostic Reproducibility of Biphasic Mesotheliomas: A Multi-Institutional Evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center
F. G. Salle, N. Le Stang, A. Nicholson, D. Pissaloux +36 more
2018Journal of Thoracic Oncology82 citations Open access
Semantic Scholar
Abstract CT003: Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo as neoadjuvant treatment (tx) for resectable (IB-IIIA) non-small cell lung cancer (NSCLC) in the phase 3 CheckMate 816 trial
P. Forde, J. Spicer, Shun Lu, M. Provencio +16 more
2021Clinical Trials69 citations
Semantic Scholar
Using DNA sequencing data to quantify T cell fraction and therapy response
R. Bentham, K. Litchfield, T. Watkins, Emilia L. Lim +288 more
2021Nature62 citations Open access
Semantic Scholar
Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe
D. Horgan, G. Curigliano, O. Riess, P. Hofman +16 more
2022Journal of Personalized Medicine57 citations Open access
Semantic Scholar
Cytology for PD-L1 testing: A systematic review.
J. Gosney, A. Boothman, M. Ratcliffe, K. Kerr
2020Lung Cancer57 citations Open access
Semantic Scholar
Comprehensive Molecular and Pathologic Evaluation of Transitional Mesothelioma Assisted by Deep Learning Approach: A Multi-Institutional Study of the International Mesothelioma Panel from the MESOPATH Reference Center
F. G. Salle, N. Le Stang, F. Tirode, P. Courtiol +50 more
2020Journal of Thoracic Oncology56 citations Open access
Semantic Scholar
Prognostic impact of KRAS G12C mutation in patients with NSCLC: results from the ETOP Lungscape Project.
S. Finn, A. Addeo, U. Dafni, E. Thunnissen +20 more
2021Journal of Thoracic Oncology53 citations Open access
Semantic Scholar
A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape Project.
K. Kerr, E. Thunnissen, U. Dafni, S. Finn +32 more
2019Lung Cancer50 citations Open access
Semantic Scholar
Expert opinion on NSCLC small specimen biomarker testing — Part 1: Tissue collection and management
F. Penault-Llorca, K. Kerr, P. Garrido, E. Thunnissen +8 more
2022Virchows Archiv46 citations Open access
Semantic Scholar
Navigating Diagnostic and Treatment Decisions in Non‐Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team Approach
S. Popat, N. Navani, K. Kerr, E. Smit +4 more
2020The Oncologist46 citations Open access
Semantic Scholar
Antibody-drug conjugates in lung and breast cancer: Current evidence and future directions - a position statement from the ETOP IBCSG Partners Foundation.
S. Peters, S. Loi, F. André, S. Chandarlapaty +11 more
2024Annals of Oncology45 citations
Semantic Scholar
Molecular testing in stage I-III non-small cell lung cancer: Approaches and challenges.
C. Aggarwal, L. Bubendorf, W. Cooper, P. Illei +5 more
2021Lung Cancer45 citations Open access
Semantic Scholar
Expert opinion on NSCLC small specimen biomarker testing — Part 2: Analysis, reporting, and quality assessment
F. Penault-Llorca, K. Kerr, P. Garrido, E. Thunnissen +8 more
2022Virchows Archiv41 citations Open access
Semantic Scholar
BTS guideline for the investigation and management of malignant pleural mesothelioma
I. Woolhouse, L. Bishop, L. Darlison, D. de Fonseka +13 more
2018BMJ Open Respiratory Research40 citations Open access
Semantic Scholar
Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
C. Abbosh, N. Birkbak, G. Wilson, M. Jamal-Hanjani +100 more
2017Nature40 citations Open access
Semantic Scholar
Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project
K. Kerr, U. Dafni, K. Schulze, E. Thunnissen +38 more
2018Annals of Oncology39 citations Open access
Semantic Scholar
Defining morphologic features of invasion in pulmonary non-mucinous adenocarcinoma with lepidic growth - A proposal by the IASLC Pathology Committee.
E. Thunnissen, M. Beasley, A. Borczuk, S. Dacic +28 more
2022Journal of Thoracic Oncology38 citations Open access
Semantic Scholar
Bringing Greater Accuracy to Europe’s Healthcare Systems: The Unexploited Potential of Biomarker Testing in Oncology
D. Horgan, G. Ciliberto, P. Conte, D. Baldwin +45 more
2020Biomedicine hub37 citations Open access
Semantic Scholar
Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary Pathologists
C. Lindsay, E. Shaw, D. Moore, D. Rassl +23 more
2021British Journal of Cancer33 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Nicholson×19
Invite
A. Nicholson — researcher profile on SciRah
E. Thunnissen×17
Invite
E. Thunnissen — researcher profile on SciRah
M. Beasley×15
Invite
M. Beasley — researcher profile on SciRah
S. Dacic×15
Invite
S. Dacic — researcher profile on SciRah

×14

Invite

M. Tsao — researcher profile on SciRah

S. Lantuejoul×12

Invite

S. Lantuejoul — researcher profile on SciRah

Invite

L. Sholl — researcher profile on SciRah

Invite

F. Hirsch — researcher profile on SciRah

Invite

Y. Yatabe — researcher profile on SciRah

F. Blackhall×12

Invite

F. Blackhall — researcher profile on SciRah

L. Bubendorf×10

Invite

L. Bubendorf — researcher profile on SciRah

Invite

D. Moore — researcher profile on SciRah